Abstract
We previously reported new zinc complexes of allixin [bis(allixinato)zinc] and its derivative bis(thioallixin-N-methyl)zinc that demonstrated excellent antidiabetic activity in type 2 diabetic mellitus KKAy mice. However, the molecular mechanism of these complexes is not fully understood. Thus, we attempted to reveal the intracellular mechanism of these complexes in 3T3-L1 adipocytes. Both zinc complexes induced Akt/protein kinase B (Akt/PKB) phosphorylation. The phosphorylation of Akt/PKB enhanced glucose transporter 4 translocation to the plasma membrane; this in turn enhanced the glucose utilization in a dose- and time-dependent manner. Glucose utilization by the complexes depended on the intracellular zinc concentration. Moreover, zinc complexes suppressed the cyclic AMP dependent protein kinase mediated phosphorylation of hormone-sensitive lipase (HSL), leading to the inhibition of free fatty acid release from the 3T3-L1 adipocytes. Such responses were inhibited by wortmannin, suggesting that the suppression of HSL by zinc complexes was dependent in the phosphoinositide 3-kinase–Akt/PKB signaling cascade. On the basis of these results, we proposed that both zinc complexes activated the Akt/PKB-mediated insulin-signaling pathway and improved both glucose utilization and lipid metabolism.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance
- BSA:
-
Bovine serum albumin
- cAMP:
-
Cyclic AMP
- DM:
-
Diabetes mellitus
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- FBS:
-
Fetal bovine serum
- FFA:
-
Free fatty acid
- GLUT4:
-
Glucose transporter 4
- HSL:
-
Hormone-sensitive lipase
- IBMX:
-
3-Isobutyl-1-methylxanthine
- IRβ:
-
Insulin receptor β-subunit
- 2-NBDG:
-
2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-deoxy-d-glucose
- PBS:
-
Phosphate-buffered saline
- PDE:
-
Phosphodiesterase
- PDE3B:
-
Phosphodiesterase 3B
- PI3K:
-
Phosphoinositide 3-kinase
- PKA:
-
Cyclic AMP dependent protein kinase
- PKB:
-
Protein kinase B
- PTEN:
-
Phosphatases and tensin homologue deleted chromosome 10
- Zn(alx)2 :
-
Bis(allixinato)zinc
- Zn(tanm)2 :
-
Bis(thioallixin-N-methyl)zinc
References
Guyton AC, Hall JE (eds) (2006) Textbook of medical physiology, 11th edn. Elsevier Saunders, Philadelphia
American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl. 1):S43–S48
Turkoski BB (2006) Orthop Nurs 25:227–231
Moller DE (2001) Nature 414:821–827
Sakurai H (2002) Chem Rec 2:237–248
Sakurai H, Fujisawa Y, Fijimoto S, Yasui H, Takino T (1999) J Trace Elem Exp Med 12:393–401
Sakurai H, Fujii K, Watanabe H, Tamura H (1995) Biochem Biophys Res Commun 214:1095–1101
Sakurai H, Yasui H, Adachi Y (2003) Expert Opin Investig Drugs 12:1189–1203
Sakurai H, Katoh A, Yoshikawa Y (2006) Bull Chem Soc Jpn 79:1645–1664
Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y (2001) Biochem Biophys Res Commun 281:1190–1193
Adachi Y, Yoshida J, Kodera Y, Kato A, Yoshikawa Y, Kojima Y, Sakurai H (2004) J Biol Inorg Chem 9:885–893
Adachi Y, Yoshikawa Y, Yoshida J, Kodera Y, Katoh A, Kojima Y, Sakurai H (2006) Biomed Res Trace Elem 17:17–24
Adachi Y, Yoshida J, Kodera Y, Sakurai H (2005) Chem Lett (Jpn) 34:656–657
Yoshikawa Y, Ueda E, Kojima Y, Sakurai H (2004) Life Sci 75:741–751
Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, Yoshikawa Y, Sakurai H (2006) Biochem Biophys Res Commun 351:165–170
Saltiel AR, Kahn CR (2001) Nature 414:799–806
Taniguchi CM, Emanuelli B, Kahn CR (2006) Nature Rev Mol Cell Biol 7:85–96
Thong FSL, Dugani CB, Klip A (2005) Physiology 20:271–284
Chang L, Chiang SH, Saltiel AR (2004) Mol Med 10:65–71
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemming BA (1995) Nature 378:785–789
Watson RT, Pessin JE (2006) Trends Biochem Sci 31:215–222
Min J, Okada S, Kanzaki M, Elmendorf JS, Coker KJ, Ceresa BP, Syu LJ, Noda Y, Saltiel AR, Pessin JE (1999) Mol Cell 3:751–760
Watson RT, Kanzaki M, Pessin JE (2004) Endocr Rev 25:177–204
Basuki W, Hiromura M, Adachi Y, Tayama K, Hattori M, Sakurai H (2006) Biochem Biophys Res Commun 349:1163–1170
Langin D (2006) Pharmacol Res 53:482–491
Carmen GY, Víctor SM (2006) Cell Signal 18:401–408
Schweiger M, Schreiber R, Heammerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R (2006) J Biol Chem 281:40236–40241
Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganiello (1990) Proc Natl Acad Sci 87:533–537
Anthonsen MW, Rönnstrand L, Wernstedt C, Degerman E, Holm C (1998) J Biol Chem 273:215–221
Garton AJ, Yeaman SJ (1990) Eur J Biochem 191:245–250
Greenberg AS, Shen W, Muliro K, Patel S, Souza SC, Toth RA, Kraemer FB (2001) J Biol Chem 276:45456–45461
Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M (1999) Mol Cell Biol 19:6286–6296
Kurioka S, Murakami Y, Nishiki M, Sohmiya M, Koshimura K, Kato Y (2002) Endocr J 49: 459–464
Raz I, Eldor R, Cernea S, Shafrir E (2005) Diabetes Metab Res Rev 21:3–14
Cersosimo E, DeFronzo RA. (2006) Diabetes Metab Res Rev 22:423–436
Hiromura M, Nakayama A, Adachi Y, Doi M, Sakurai H (2007) J Biol Inorg Chem 12:1275–1287
Ishiki M, Randhawa VK, Poon V, Jebailey L, Klip A (2005) J Biol Chem 280:28792–28802
Yoshioka K, Takahashi H, Homma T, Saito M, Oh KB, Nemoto Y, Matsuoka H (1996) Biochim Biophys Acta 1289:5–9
Ludbrook J (1998) Clin Exp Pharmacol Physiol 25:1032–1037
Draznin B (2006) Diabetes 55:2392–2397
Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA (2005) Ann Clin Biochem 42:364–375
Cohen N, Golik A (2006) Heart Fail Rev 11:19–24
Haase H, Maret W (2005) Biometals 18:333–338
Zhuo S, Dixon JE (1997) Protein Eng 10:1445–1452
Wu W, Wang X, Zhang W, Reed W, Samet JM, Wang YE, Ghio AJ (2003) J Biol Chem 278:28258–28263
Kim S, Jung Y, Kim D, Koh H, Chung J (2000) J Biol Chem 275:25979–25984
Lynch CJ, Patson BJ, Goodman SA, Trapolsi D, Kimball SR (2001) Am J Physiol Endocrinol Metab 281:E25–E34
Eom SJ, Kim EY, Lee JE, Kang HJ, Shim J, Kim SU, Gwag BJ, Choi EJ (2001) Mol Pharm 59:981–986
Tan XH, Shay NF (2001) J Nutr 131:1414–1420
Basuki W, Hiromura M, Sakurai H (2007) Bull Chem Soc Jpn 80:1605–1610
Basuki W, Hiromura M, Sakurai H (2007) J Inorg Biochem 101:692–699
Yamada K, Nakata M, Horimoto N, Saito M, Matsuoka H, Inagaki N (2000) J Biol Chem 275:22278–22283
Frayn KN (2002) Diabetologia 45:1201–1210
Boden G, Shulman GI (2002) Eur J Clin Invest 32:14–23
Nisoli E, Carruba MO (2004) Pharmacol Res 50:453–469
Ahmad F, Lindh R, Tang Y, Weston M, Dergerman E, Manganiello VC (2007) Biochem J 404: 257–268
Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganiello VC (1990) Proc Natl Acad Sci USA 87:533–537
Eriksson H, Ridderstrale M, Degerman E, Ekholm D, Smith CJ, Manganiello VC, Belfrage P, Tornqvist H (1995) Biochim Biophys Acta 1266:101–107
Acknowledgments
This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [Grant-in-Aid for Scientific Research (B). Scientific Research on Priority Areas, and Specially Promoted Research] to H.S.
Author information
Authors and Affiliations
Corresponding author
Additional information
A. Nakayama and M. Hiromura contributed equally to this work.
Rights and permissions
About this article
Cite this article
Nakayama, A., Hiromura, M., Adachi, Y. et al. Molecular mechanism of antidiabetic zinc–allixin complexes: regulations of glucose utilization and lipid metabolism. J Biol Inorg Chem 13, 675–684 (2008). https://doi.org/10.1007/s00775-008-0352-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-008-0352-0